Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]
News [6479]
Articles [133]
Editorials [5]
Conferences [171]
elearning [10]
Predictors of efficacy in patients with HR positive/HER2 negative ABC: Subgroup...
Prof Hope Rugo - University of California, San Francisco, USA
Predictors of efficacy in patients with HR positive/HER2 negative ABC: Subgroup analyses of PALOMA-3 ( Prof Hope Rugo - University of California, San Francisco, USA )
23 Nov 2020
Using circulating tumour DNA dynamics to predict outcomes in advanced cancers
Dr Mohamed Gouda - The University of Texas MD Anderson Cancer Center, Houston...
Using circulating tumour DNA dynamics to predict outcomes in advanced cancers ( Dr Mohamed Gouda - The University of Texas MD Anderson Cancer Center, Houston, USA )
23 Nov 2020
OncoAlert and ecancer weekly roundup for November 8 - 14, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for November 8 - 14, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Nov 2020
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020
Dr Gil Morgan - Skåne University Hospital, Lund, Sweden
OncoAlert and ecancer weekly roundup for November 2 - 7, 2020 ( Dr Gil Morgan - Skåne University Hospital, Lund, Sweden )
9 Nov 2020
SAFIR 02: Durvalumab compared to maintenance chemotherapy for metastatic non...
Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
SAFIR 02: Durvalumab compared to maintenance chemotherapy for metastatic non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020
PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer
Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020
Sotorasib for advanced non-small cell lung cancer
Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France
Sotorasib for advanced non-small cell lung cancer ( Prof Fabrice Barlesi - Gustave Roussy, Villejuif, France )
6 Nov 2020
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation
Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation ( Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA )
4 Nov 2020
Development of novel inhibitors of KRASG12C
Dr Kevan Shokat - University of California San Francisco, San Francisco, USA
Development of novel inhibitors of KRASG12C ( Dr Kevan Shokat - University of California San Francisco, San Francisco, USA )
4 Nov 2020
Critical issues in drug and biomarker development
Prof Tracy Lively - National Cancer Institute, USA
Critical issues in drug and biomarker development ( Prof Tracy Lively - National Cancer Institute, USA )
2 Nov 2020
OncoAlert and ecancer weekly roundup for October 26 - 31, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 26 - 31, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
2 Nov 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation